期刊文献+

内源性硫化氢在大鼠黑质氧化损伤中的变化及作用 被引量:1

Changes and roles of endogenous hydrogen sulfide in the substantial nigra oxidative damage of rats
下载PDF
导出
摘要 目的观察大鼠黑质氧化损伤后内源性硫化氢(hydrogen sulfide,H2S)的变化及其作用。方法将SD雄性大鼠单侧黑质内微量注射6-羟基多巴胺(6-Hydroxydopamine,6-OHDA)作为黑质氧化损伤模型;H2S供体硫氢化钠(sodium hydrosulfide,Na HS)在6-OHDA损伤前连续腹腔注射3周作为预处理;实验分为对照组、6-OHDA损伤后7 d(D7组)、11 d(D11组)、17 d组(D17组)、Na HS预处理组(Na HS+6-OHDA处理),每组各8只;采用亚甲基蓝分光光度计法检测黑质胱硫醚-β-合酶(cystathionine-β-synthase,CBS)活性及H2S的含量;免疫组织化学法检测黑质酪氨酸羟化酶(tyrosine hydroxylase,TH)阳性细胞数;紫外分光光度法测定黑质谷胱甘肽过氧化物酶(glutathione peroxidase,GSH-Px)活性和丙二醛(malondialdehyde,MDA)水平。结果与对照组比较,6-OHDA损伤后7、11、17 d黑质CBS酶活性分别下降为[(96.21±8.40)%,P>0.05],[(86.48±9.85)%,P<0.05]和[(75.16±7.45)%,P<0.01];内源性H2S含量分别减少为[(90.12±10.03)%,P<0.05],[(82.58±9.52)%,P<0.01]和[(78.16±11.55)%,P<0.01]。TH阳性细胞与对照组比较,在6-OHDA损伤后7 d即下降为[(84.32±6.06)%,P<0.05],同时伴随黑质GSH-Px活性降低及MDA含量升高,差异有统计学意义(P<0.05)。但早期给予Na HS预处理补充H2S之后,与单纯6-OHDA损伤后7 d比较,TH阳性细胞则增加为[(96.15±5.03)%,P<0.05],且黑质GSH-Px的活性升高,MDA的含量降低,差异有统计学意义(P<0.05)。结论 6-OHDA氧化损伤导致大鼠黑质CBS酶活性及H2S含量下降,外源性H2S预处理可早期发挥抗黑质氧化损伤的神经元保护作用,这可能与其增加GSH-Px活性及减少MDA含量有关。 Objective To observe the changes and roles of endogenous hydrogen sulfide in the substantia nigra oxidative damage of rats. Methods 6-hydroxydop- amine(6-OHDA) was microinjected in the unilateral substantia nigra of SD rats as the substantia nigra oxidative damage model; H2 S donor, sodium hydrosulfide(Na HS) was injected intraperitoneally for three consecutive weeks as a pretreatment before 6-OHDA injury. The experiment were divided into the control group, 7 days(D7) group, 11 days(D11) group, 17 days(D17) group after 6-OHDA injury and Na HS preconditioning group(deafed with Na HS + 6-OHDA); with 8 rats in each group. Cystathionine-β-synthase(CBS) activity and H2 S production in substantia nigra were detected by methylene blue spectrophot-ometric method. Immunohistochemistry was used to detect tyrosine hydroxylase(tyrosine hydroxylase, TH) positive cells of the substantia nigra; Glutathione peroxidase(GSH-Px) activity and malondialdehyde(MDA) level of the substantia nigra were measured by UV spectrophotometry. Results Compared with the control group, percentage of CBS activity was decreased respectively to [(96.21 ±8.40)%, P〈0.05], [(86.48 ±9.85)%, P〈0.05 ] and [(75.16±7.45)%, P〈0.01] for 7,11 and 17 d after 6-OHDA injury; Percentage of endogenous H2 S content decreased respectively to[(90.12±10.03)%, P〈0.05],[(82.58±9.52)%, P〈0.01]and [(78.16 ±11.55)%, P〈0.01] also. Compared with control group, percentage of TH positive cells was reduced to[(84.32±6.06)%, P〈0.05] at 7 d after 6-OHDA damage, accompanied by GSH-Px activity reducing and MDA content increasing, the difference was statistically significant(P〈0.05). But compared with 7 d after 6-OHDA injury, early supplementary H2 S through Na HS pretreatment, percentage of TH positive cells were increased to [(96.15±5.03)%, P〈0.05], and GSH-Px activity was increased,the content of MDA was decreased, the difference was statistically significant(P〈0.05). Conclusion Substantia nigra oxidative damage after 6-OHDA injure leads to CBS activity and endogenous H2 S content decreased, pretreatment with exogenous H2 S early exert neurons protective effect of anti- oxidative damage in substantia nigra, which may be related to GSH-Px activity increasing and MDA content decreasing.
出处 《中国医药导报》 CAS 2014年第36期16-20,共5页 China Medical Herald
基金 广东省教育厅科研项目(编号2012LYM_0083) 广东省医学科学研究基金(编号A2011295) 广东省高等院校学科建设专项(编号1057313016) 广东药学院大学生创新创业训练计划项目
关键词 硫化氢 胱硫醚-β-合酶 帕金森病 氧化应激 神经保护 Hydrogen sulfide Cystathionine-β-synthase Parkinson's disease Oxidative stress Neuroprotection
  • 相关文献

参考文献22

  • 1Morrison LD,Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease [J]. J Neurochem, 1996,67(3) : 1328-1331.
  • 2Wong PT,Qu K,Chimon GN,et al. High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke : possible involvement of hydrogen sulfide [J]. J Neuropathol Exp Neurol, 2006,65 (2) : 109 - 115.
  • 3Hu LF,Lu M,Tiong CX,et al. Neuroprotective effects of hy- drogen sulfide on Parkinson's disease rat models [J]. Aging Ce11,2010,9(2) : 135-146.
  • 4Moore DJ,West AB, Dawson VL ,et al. Molecular patho- physiology of Parkinson's disease [J]. Annu Rev Neurosci, 2005,28 : 57-87.
  • 5Yoo MS, Chun HS, Son JJ, et al. Oxidative stress regulated genes in nigral dopaminergic neuronal ceils: correlation with the known pathology in Parkinson's disease [J]. Brain Res Mol Brain Res, 2003,110 ( 1 ) : 76-84.
  • 6Kimura Y,Kimura H. Hydrogen sulfide protects neurons from oxidative stress [J]. Faseb J,2004,18(10):1165-1167.
  • 7Kamat PK, Kalani A,Givvimani S,et al. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunc- tion induced by intracerebral-administered homocysteine in mice [J]. Neuroscience,2013,252: 302-319.
  • 8Luo Y,Yang X,Zhao S,et al. Hydrogen sulfide prevents OGD/ R-induced apoptosis via improving mitochondrial dys- function and suppressing an ROS-mediated caspase-3 pathway in cortical neurons [J]. Neurochem Int,2013,63 (8) :826-831.
  • 9Tolwani RJ,Jakowec MW,Petzinger GM,et al. Experimen- tal models of Parkinson's disease: insights from many models [J]. Lab Anim Sci, 1999,49(4):363-371.
  • 10Bove J,Prou D,Perier C ,et al. Toxin-induced models of Parkinson's disease [J]. NeuroRx,2005,2(3):484-494.

同被引文献43

  • 1Kimura H. Signaling molecules: hydrogen sulfide and polysulfide [ J]. Antioxid Redox Signal, 2015, 22:362 - 376.
  • 2Ya YP, Chi XL, Liu Ij. A hypothesis: hydrogen sulfide might be neuroprotective against subarachnoid hemorrhage induced brain in- jury[J]. Sci World J, 2014,2014:432318.
  • 3Gheibi S, Aboutaleb N, Khaksari M, et al. Hydrogen sulfide pro- tects the brain against isehemic reperfusion injury in a transient model of focal cerebral ischemia[ J]. J MolNeurosci, 2014,54:264 - 270.
  • 4Dawe GS, Han SP, Bian JS,et al. Hydrogen sulphide in the hypo- thalamus causes an ATP-sensitive K + channel dependent decrease in blood pressure in freely moving rats [ J ]. Neuroscience, 2008, 152:169 - 177.
  • 5Webb GD, Lim LH, Oh VM, et al. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery [ J ]. J PharmacolExpTher, 2008,324:876 - 882.
  • 6Kimura H. Production and physiological effects of hydrogen sulfide [ J]. Antioxid Redox Signal, 2014, 20:783 -793.
  • 7Shibuya N, Koike S, Tanaka M, et al. A novel pathway for the pro- duction of hydrogen sulfide from D-cysteine in mammalian cells [J]. Nat Commun, 2013,4:1366.
  • 8Fume J, Saeed A, Levitt MD. Whole tissue hydrogen sulfide con- centrations are orders of magnitude lower than presently accepted values[ J ]. Am J PhysiolRegnlIntegr Comp Physiol, 2008,295 : R1479 - 1485.
  • 9Kimura Y, Dargusch R, Schubert D, et al. Hydrogen sulfide pro- tects HT22 neuronal ceils from oxidative stress [ J ]. Antioxid Red- ox Signal, 2006,8:661 - 670.
  • 10Wang R. Two's company, three's a crowd: can H2 S be the third endogenous gaseous transmitter? [ J]. FASEB J, 2002,16 : 1792 - 1798.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部